Is the neutrophil-to-lymphocyte ratio a marker for differentiating between benign and malignant submandibular gland masses?
Adem BoraPublished in: Revista da Associacao Medica Brasileira (1992) (2023)
This is the first study to demonstrate that the neutrophil-to-lymphocyte ratio can be used as a biomarker in submandibular gland masses and has prognostic significance in malignant masses. In addition to fine needle aspiration biopsy results, neutrophil-to-lymphocyte ratio can be used as a biomarker.